Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
01 04 2021
Historique:
received: 11 09 2020
revised: 23 12 2020
accepted: 04 03 2021
pubmed: 16 3 2021
medline: 7 4 2021
entrez: 15 3 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has produced many calls for a vaccine. There is growing concern that vaccine hesitancy and anti-vaccination presence will dampen the uptake of a coronavirus vaccine. There are many cited reasons for vaccine hesitancy. Mercury content, autism association, and vaccine danger have been commonly found in anti-vaccination messages. It is also mused that the reduced disease burden from infectious diseases has paradoxically reduced the perceived requirement for vaccine uptake. Our analysis using Google Trends has shown that throughout the pandemic the search interest in a coronavirus vaccine has increased and remained high throughout. Peaks are found when public declarations are made, the case number increases significantly, or when vaccine breakthroughs are announced. Anti-vaccine searches, in the context of COVID-19, have had a continued and growing presence during the pandemic. Contrary to what some may believe, the burden of coronavirus has not been enough to dissuade anti-vaccine searches entirely.

Identifiants

pubmed: 33715904
pii: S0264-410X(21)00287-5
doi: 10.1016/j.vaccine.2021.03.019
pmc: PMC7936546
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1877-1881

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Am J Infect Control. 2019 Nov;47(11):1314-1318
pubmed: 31266661
Vaccine. 2019 Apr 3;37(15):2057-2064
pubmed: 30862365
Hum Vaccin Immunother. 2013 Aug;9(8):1795-801
pubmed: 23811786
PLoS Curr. 2015 Feb 25;7:
pubmed: 25789201
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Ann Ist Super Sanita. 2014;50(1):6-9
pubmed: 24695248
Vaccine. 2018 Feb 1;36(6):779-787
pubmed: 29325822
Soc Sci Med. 2017 Oct;191:168-175
pubmed: 28926775
Vaccine. 2015 Sep 22;33(39):5051-6
pubmed: 26319742
Int J Infect Dis. 2020 Jun;95:192-197
pubmed: 32305520
Adv Prev Med. 2012;2012:932741
pubmed: 23082253
J Glob Health. 2020 Jun;10(1):011003
pubmed: 32373339
Vaccine. 2018 Oct 22;36(44):6509-6511
pubmed: 29921491
Soc Sci Med. 2018 Aug;211:274-281
pubmed: 29966822

Auteurs

Samuel Pullan (S)

School of Health Sciences, Institute of Population Health, Johnston Building, The Quadrangle, University of Liverpool, Brownlow Hill, Liverpool L69 3GB, UK. Electronic address: S.J.Pullan@Liverpool.ac.uk.

Mrinalini Dey (M)

Institute of Life Course and Medical Sciences, University of Liverpool, Brownlow Hill, Liverpool L69 3BX, UK; Department of Rheumatology, Aintree Hospital, Liverpool University Hospitals NHS Foundation Trust, Lower Lane L9 7AL, UK. Electronic address: Mrinalini.Dey@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH